how long do side effects last semaglutide Effects: What You Need to Know Semaglutide Side Effects Timeline |

(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers

Regular monitoring, lab work, and physician collaboration are non-negotiable for experimental approaches

Data from the TRIUMPH-3 study showed that treatment with retatrutide (9 mg, 12 mg) led to an average weight loss of up to 55.8 lbs (22.6%) at 80 weeks in patients with severe obesity and established cardiovascular disease

As a physician-owned and operated medical spa, every treatment is guided by direct physician expertise and oversight, ensuring that your care is held to the highest standards

Pancreatitis is a serious adverse event associated with the GLP-1 receptor agonist class